Stevenage, United Kingdom

Andrew Simon Craig

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nerre Therapeutics Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Simon Craig. Retrieved from https://idiyas.com/inventor/andrew-simon-craig-xibao1jt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Simon Craig - Innovator in Pharmaceutical Compounds

Introduction

Andrew Simon Craig is a notable inventor based in Stevenage, GB, contributing to the field of pharmaceutical innovations. He has made significant strides through his research and development efforts at Nerre Therapeutics Limited.

Latest Patents

Andrew holds one patent that pertains to a compound in crystalline anhydrate form, alongside pharmaceutical formulations containing these compounds. The patent also details their therapeutic use and processes for preparation, demonstrating Craig's commitment to advancing medical science.

Career Highlights

At Nerre Therapeutics Limited, Andrew has been instrumental in pushing the boundaries of pharmaceutical research. His expertise in medicinal chemistry and innovative approaches to drug formulation have earned him recognition within the industry.

Collaborations

Andrew collaborates with talented professionals like Salima Zarah Ismail and Ronnie Maxwell Lawrence, fostering an environment of innovation and teamwork. Their joint efforts aim to develop new therapies that address unmet medical needs.

Conclusion

In summary, Andrew Simon Craig's work exemplifies the spirit of invention and innovation in the pharmaceutical realm. His patent and collaborations mark significant contributions that may transform therapeutic practices and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…